The encephalopathy of prematurity--brain injury and impaired brain development inextricably intertwined

Joseph J Volpe1

  • 1Department of Neurology, Children's Hospital and Harvard Medical School, Boston, MA 02115, USA. joseph.volpe@childrens.harvard.edu

Insights

Neonatal brain injury significantly impacts infant development, with effects extending beyond tissue loss. Understanding the "encephalopathy of prematurity" is crucial for improving neurologic outcomes in premature infants.

Area of Science:

  • Neonatal Neurology
  • Developmental Neuroscience
  • Pediatric Brain Injury

Background:

  • Neonatal neurology originated from neuropathologic studies.
  • Advanced imaging techniques have enhanced understanding of neonatal brain injury.
  • Premature infant brain injury, or "encephalopathy of prematurity," is a key focus.

Purpose of the Study:

  • To review the "encephalopathy of prematurity" in the context of late gestation development.
  • To emphasize that neonatal brain injury's effects on development are critical for neurologic outcome.
  • To highlight the interplay between destructive and developmental mechanisms in brain injury.

Main Methods:

  • Review of neuropathologic studies.
  • Analysis of advanced magnetic resonance imaging (MRI) findings.
  • Integration of developmental neurobiology insights.

Main Results:

  • Neonatal brain injury has diverse and serious effects on subsequent development.
  • The "encephalopathy of prematurity" involves complex destructive and developmental disturbances.
  • Interactions between destructive and developmental processes are central to brain injury genesis.

Conclusions:

  • Neurologic outcome is determined by more than just tissue loss.
  • Understanding developmental disturbances is key to managing "encephalopathy of prematurity."
  • Future advances will rely on neuropathology and molecular approaches.

Related Concept Videos

Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...